Amgen to Present at the Goldman Sachs Global Healthcare Conference
06.08.2009
|
THOUSAND OAKS, Calif., June 8 /PRNewswire-FirstCall/ -- Amgen (Nasdaq:
AMGN) will present at the Goldman Sachs Global Healthcare Conference on
Wednesday, June 10, 2009 at the Grand Hyatt, New York City, N.Y., beginning at
9:00 a.m. Eastern Time. Roger M. Perlmutter, Amgen's Executive Vice President
of Research & Development, will present. Live audio of the presentation will
be available over the Internet and can be accessed from Amgen's Web site,
www.amgen.com, under Investors.
Information regarding presentation time, webcast availability, and webcast
links are available on Amgen's Investor Relations Events Calendar.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by bringing safe and effective
medicines from lab, to manufacturing plant, to patient. Amgen therapeutics
have changed the practice of medicine, helping millions of people around the
world in the fight against cancer, kidney disease, rheumatoid arthritis, and
other serious illnesses. With a deep and broad pipeline of potential new
medicines, Amgen remains committed to advancing science to dramatically
improve people's lives. To learn more about our pioneering science and our
vital medicines, visit www.amgen.com.
CONTACT: Amgen, Thousand Oaks
David Polk, 805-447-4613 (media)
John Shutter, 805-447-1060 (investors)
(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)
SOURCE Amgen
